Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong · Delayed Price · Currency is HKD 54.10
+0.85 (1.60%)
Jul 30, 2026, 4:08 PM HKT
Shanghai Henlius Biotech Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 6,667 | 6,667 | 5,724 | 5,395 | 3,215 | 1,682 |
Revenue Growth | 14.98% | 16.46% | 6.11% | 67.82% | 91.07% | 186.34% |
Gross Profit Gross Profit Growth | 4,985 | 4,985 | 4,185 | 3,919 | 2,370 | 1,160 |
Operating Income Operating Income Growth | 817.12 | 817.12 | 866.5 | 652.95 | -628.53 | -665.25 |
Net Income Net Income Growth | 827.04 | 827.04 | 820.47 | 546.02 | -695.26 | -984.05 |
Earnings Per Share EPS Growth | 1.51 | 1.51 | 1.51 | 1.00 | -1.28 | -1.83 |
EPS Growth | -0.44% | 0.03% | 50.96% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Chinese Mainland Chinese Mainland Growth | 5,782 | 5,782 | 5,046 | 4,811 | 2,841 | 1,516 |
Asia Pacific (Excluding Chinese Mainland) Asia Pacific (Excluding Chinese Mainland) Growth | 116.01 | 116.01 | 236.86 | 193.99 | 178.97 | 57.29 |
North America North America Growth | 465.47 | 465.47 | 329.12 | 314.79 | 145.06 | - |
South America South America Growth | 27.58 | 27.58 | 10.62 | 19.14 | - | - |
Europe Europe Growth | 275.8 | 275.8 | 101.41 | 56.37 | 50.14 | 109.54 |
Oceania Oceania Growth | - | - | 0.33 | - | - | - |
Total Total Growth | 6,667 | 6,667 | 5,724 | 5,395 | 3,215 | 1,682 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 843.25 | 843.25 | 813.73 | 1,009 | 711.87 | 742.32 |
Total Debt Total Debt Growth | 3,597 | 3,597 | 3,648 | 4,093 | 3,677 | 2,623 |
Net Cash (Debt) Net Cash Growth | -2,754 | -2,754 | -2,834 | -3,084 | -2,965 | -1,881 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -5.04 | -5.04 | -5.22 | -5.68 | -5.47 | -3.49 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,306 | 1,306 | 1,242 | 1,048 | 981.62 | 90.39 |
Capital Expenditures CapEx Growth | -311.37 | -311.37 | -164.01 | -473.67 | -584.97 | -460.43 |
Free Cash Flow Free Cash Flow Growth | 994.25 | 994.25 | 1,078 | 574.25 | 396.65 | -370.04 |
Free Cash Flow Growth | -34.92% | -7.76% | 87.70% | 44.77% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 74.77% | 74.77% | 73.10% | 72.64% | 73.73% | 68.93% |
Operating Margin | 12.26% | 12.26% | 15.14% | 12.10% | -19.55% | -39.54% |
Pretax Margin | 12.18% | 12.18% | 14.78% | 10.56% | -21.58% | -56.87% |
Profit Margin | 12.41% | 12.41% | 14.33% | 10.12% | -21.63% | -58.49% |
FCF Margin | 14.91% | 14.91% | 18.83% | 10.64% | 12.34% | -21.99% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 31.69 | 33.69 | 14.75 | 12.56 | - | - |
Forward PE | 20.61 | 27.52 | 15.91 | 12.55 | - | - |
P/FCF Ratio | 26.16 | 28.02 | 11.23 | 11.94 | 15.51 | - |
PS Ratio | 3.90 | 4.18 | 2.11 | 1.27 | 1.91 | 5.80 |